The scale doesn't move first.
The food noise quiets first. Before-and-after photos show body changes, but the real before/after for most GLP-1 patients happens in their head, in the first 7 to 10 days, when the constant background hum of "what should I eat next" goes silent. Then weight starts to move at week 3 to 4, and the visual changes catch up at month 2 to 3.
Here's the realistic timeline, the clinical numbers, and what to expect when, based on the actual trial data, not social media transformations.
Real GLP-1 before and after results
Four real before-and-after photos from users online who shared their GLP-1 results. Identifiers blurred for privacy. Click any photo to expand.
Photos sourced from users online who publicly shared their GLP-1 results. All four used compounded semaglutide or tirzepatide, the same medications available through MEDVi and Yucca Health telehealth. Individual results vary; trial average is 15-20% body weight loss at 60+ weeks.
🔑 Key Takeaways
- Appetite changes show up in week 1. Weight loss accelerates around week 3 to 4 once you titrate up.
- Average semaglutide patient: 6% body weight at 12 weeks, 15% at 68 weeks (STEP-1 trial).
- Average tirzepatide patient: 9% at 12 weeks, 21% at 72 weeks (SURMOUNT-1 trial).
- Visible body changes lag behind scale changes by about 4 weeks.
- Plateaus at month 4 to 6 are normal. They mean you're due for a dose increase, not that the drug stopped working.
What clinical trials show vs what social media shows
Social media transformations are the top 5% of patients, photographed in the best possible lighting, after 6 to 12 months. Clinical trial averages are the middle of the bell curve. Anchor your expectations to the trial data, not the highlight reel.
| Drug | 12 weeks | 6 months | 12 months | 18 months |
|---|---|---|---|---|
| Semaglutide 2.4mg (Wegovy) | ~6% | ~10% | ~13% | ~15% (STEP-1) |
| Tirzepatide 15mg (Zepbound) | ~9% | ~15% | ~19% | ~21% (SURMOUNT-1) |
| Liraglutide 3mg (Saxenda) | ~4% | ~6% | ~8% | — |
| Retatrutide 12mg (investigational) | ~12% | ~17% | ~24% | — (Phase 2) |
Month-by-month timeline
Week 1: appetite shift
Food noise drops within the first 3 to 7 days. You eat your usual lunch and feel full halfway through. Snack thoughts that ran on a loop go quiet. Some mild nausea (especially the first 48 hours after each injection) is common. Scale rarely moves yet because you're on the starter dose, which is sub-therapeutic by design (it's a tolerance-builder, not a weight-loss dose).
Weeks 2 to 4: first real losses
Most patients lose 3 to 8 lbs by the end of week 4. The dose typically titrates up at week 4. Constipation peaks here for many patients. Energy can dip if protein and water aren't consistent.
Months 2 to 3: visible changes
This is when face leanness shows up first (the "Ozempic face" headline is real, but it just means you're losing facial fat). Clothes start fitting differently. Average loss by end of month 3 is 8 to 12% body weight depending on starting weight and drug.
Months 4 to 6: the first plateau
Almost every patient hits a 2 to 4 week plateau somewhere between month 4 and month 6. This is normal. It usually resolves by titrating to the next dose tier. Patients who panic and quit during this window are the main reason long-term results disappoint; the people who stay on through month 6 keep losing.
Months 7 to 12: continued grinding
Weight loss slows from 1 to 2 lbs/week to 0.5 to 1 lb/week. Body composition keeps shifting. Most STEP-1 trial participants hit their personal low around month 12 to 14.
Beyond month 12: maintenance
Once you hit your goal weight, the conversation shifts to maintenance. Many patients stay on a lower maintenance dose. Some titrate down with their clinician. Stopping cold reliably leads to regain (about two-thirds of lost weight in 12 months in trial data), so the off-ramp deserves a real conversation, not an abrupt stop.
What changes first (besides the scale)
- Food noise. Days 3 to 7. The constant mental loop quiets.
- Portion comfort. Week 2. You feel full sooner and stay full longer.
- Sleep quality. Weeks 3 to 4. Less heartburn, less sugar crash, deeper sleep.
- Face/jawline definition. Months 1 to 2. First visible change for most patients.
- Waist circumference. Months 2 to 3. The clothes-fitting-different milestone.
- Knee, back, joint pain reduction. Months 3 to 4. Often the most appreciated outcome.
- Energy and mood. Months 3 to 6. Once protein/sleep/movement stabilize.
Why some people lose less
About 15% of patients are "low responders" who lose less than 5% body weight at 12 weeks. The most common reasons:
- Stuck at a low dose. Side effects scared them away from titrating up.
- Inconsistent injections. Skipping or delaying weekly doses.
- Genetic GLP-1 receptor variation. Real but rare; affects maybe 2 to 5% of patients.
- Underlying medication interference. Some antipsychotics and corticosteroids work against GLP-1 effects.
- Eating around the medication. Liquid calories (smoothies, juices, alcohol) bypass the satiety mechanism.
If you're in the low-responder zone at week 12, talk to your clinician about switching from semaglutide to tirzepatide (the latter outperforms in head-to-head data) before assuming GLP-1s "don't work for you."
If you're ready for the prescription route: MEDVi or Yucca
Two telehealth providers cover the full pipeline in 2026. Both ship from US pharmacies. Both review your file with a US-licensed clinician. Both turn around in 24 to 72 hours.
MEDVi: brand and compounded, broadest formulary
Prescribes Wegovy, Zepbound, compounded semaglutide, and compounded tirzepatide. Dietician visits and 24/7 portal support are bundled. From around $199/mo on compounded.
Signup in 4 steps: open the MEDVi intake, complete the 15-minute medical history, upload your ID, and wait for the clinician to message you. Approval lands within 24 to 72 hours. First shipment arrives in 3 to 5 days, cold-packed from a US pharmacy.
Yucca Health: lowest cash price on compounded
Compounded semaglutide from $146/mo and compounded tirzepatide from $258/mo on the 6-month plan. No membership fees, no consultation charge.
Signup in 4 steps: open the Yucca eligibility quiz, pick semaglutide or tirzepatide on a 1, 3, or 6-month plan, verify ID with a license photo, and a board-certified physician reviews. Most weekday morning submissions are approved same-day. Pharmacy ships in 2 to 4 days.
Full breakdown of every step, costs, and red flags is in the telehealth GLP-1 guide.
The honest version of "before and after"
Most realistic outcome at month 12 on a steady protocol: 12 to 18% body weight loss, more visible facial leanness, better sleep, less joint pain, smaller waist, but still imperfect. The dramatic transformations (50+ lbs in 6 months) are usually patients with very high starting weights or aggressive protein deficits. Match your expectations to your starting point and the drug's average. That's how you stay on long enough to actually win.
Frequently Asked Questions
Medical Disclaimer: This article is for informational purposes only and is not medical advice. GLP-1 medications including semaglutide and tirzepatide are prescription drugs that require evaluation by a licensed clinician. Always disclose your full medical history during intake, follow your prescribing clinician's titration schedule, and seek in-person care for severe side effects including persistent abdominal pain, signs of pancreatitis, or allergic reactions. Compounded GLP-1 medications are dispensed under FDA 503A and 503B oversight but are not FDA-approved finished products.